Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes-Reference-Cited by-同舟云学术

Vortioxetine versus sertraline in metabolic control, distress and depression in Mexican patients with type 2 diabetes

Published:2019-11 Issue:22 Volume:7 Page:656-656
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann. Transl. Med.

Author:

Tovilla-Zárate Carlos Alfonso,Pérez-Mandujano Antonia,Ramírez-González Iris Rubí,Fresan Ana,Suarez-Mendez Samuel,Martínez-Villaseñor Esteban,Rodríguez-Sánchez Ester,Villar-Soto Mario,López-Narváez María Lilia,González-Castro Thelma Beatriz,Ble-Castillo Jorge L.,Juárez-Rojop Isela Esther

Publisher

AME Publishing Company

Subject

General Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine versus reuptake inhibitors in adults with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials;Asian Journal of Psychiatry;2024-11

2. Depression in type 2 diabetes mellitus: Prevalence, characteristics, associated factors, and treatment outcomes;Endocrine and Metabolic Science;2024-09

3. A Randomized Controlled Trial Comparing the Effects of Vilazodone, Escitalopram, and Vortioxetine Monotherapy on the Metabolic Parameters in Patients With Major Depressive Disorder;Cureus;2024-08-27

4. Trajectory of the body mass index of children and adolescents attending a reference mental health center;Journal of Pediatric Endocrinology and Metabolism;2024-04-19

5. Effect of Vortioxetine in Comparison to Fluoxetine on Metabolic Parameters in Patients With Depressive Disorder: A Randomized Controlled Trial;Cureus;2024-01-29